Inclusive of all taxes
Voglibose, Glimepiride & Metformin HCl (SR) Tablets offer a comprehensive pharmaceutical solution specifically designed for effective diabetes management. This triple combination tablet integrates the alpha-glucosidase inhibitor (Voglibose), a sulfonylurea class hypoglycemic agent (Glimepiride), and Metformin Hydrochloride sustained-release formulation to optimize glycemic control in patients with type 2 diabetes. Manufactured under stringent WHO-GMP compliant facilities by IndiGlobal Exports, this formulation guarantees consistent dosage, therapeutic efficacy, and safety adhering to international export quality standards. The sustained-release Metformin component in the blend allows for improved bioavailability and extended therapeutic effect, reducing dosing frequency while minimizing gastrointestinal side effects commonly associated with immediate-release formulations. Packaged in export-grade blister or strip packs, these tablets ensure product stability and facilitate easy carriage for bulk commercial distribution. Approved for hospital, retail pharmacy, and institutional uses, these tablets are integral for clinical protocols aiming at effective and reliable glycemic control, thus reducing the risks of diabetes-related complications and improving patient outcomes.
Key Features
| Features | Description |
|---|---|
| Therapeutic Components | Voglibose, Glimepiride, Metformin HCl (Sustained Release) |
| Indication | Management of Type 2 Diabetes Mellitus |
| Dosage Form | Oral Tablets |
| Formulation Type | Sustained Release (Metformin component) |
| Packaging | Export-grade blister or strip packs |
| Manufacturing Standards | WHO-GMP compliant facilities |
| Quality Compliance | IP/USP Pharmacopoeial Standards |
| Shelf Life | As per regulatory standards |
| Market Suitability | International export and regulated/semi-regulated markets |
| Attributes | Description |
|---|---|
| Active Pharmaceutical Ingredients | Voglibose, Glimepiride, Metformin Hydrochloride (SR) |
| Pharmaceutical Category | Antidiabetic Medication |
| Manufacturer | IndiGlobal Exports |
| Formulation | Tablet |
| Packaging | Blister/Strip Packs with export-grade material |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Regulatory Compliance | Complies with international healthcare regulations |
| Intended Use | Clinical management of diabetes mellitus type 2 |
| Mode of Action | Combination therapy targeting postprandial and fasting blood glucose |
| Shelf Life | Typically 24 months (subject to regulatory approval) |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The sustained-release Metformin component improves bioavailability and prolongs therapeutic action, allowing for reduced dosing frequency and minimized gastrointestinal side effects compared to immediate-release formulations.
Yes, the tablets are manufactured under WHO-GMP facilities and comply with IP/USP pharmacopoeial standards, making them suitable for regulated and semi-regulated international markets.
The tablets are available in export-grade blister or strip packs designed to ensure product stability and convenience for bulk shipping and institutional supply.
Yes, the formulation is designed for use in both hospital inpatient care and retail pharmacy settings, providing flexible options for diabetes management.
This formulation is intended primarily for the management of type 2 diabetes mellitus patients requiring combination therapy for effective glycemic control.
Brand: indiglobal exports
Country Of Origin: India
Voglibose, Glimepiride & Metformin HCl (SR) Tablets is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Voglibose, Glimepiride & Metformin HCl (SR) Tablets is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
